Cancer Immunology and Immunotherapy – CII
Dr. Syed Quadri
Syed Quadri
CII
Review Branch Personnel
Review Branch Summary
Will consider applications on preclinical and early clinical studies of treatments for cancer. Specifically, the CII branch reviews applications on understanding the immunology associated with cancer and the development and understanding of immunotherapies for cancer treatment.
Study Sections
- Cellular Immunotherapy of Cancer CIC
- Translational Immuno-oncology TIO
- Therapeutic Immune Regulation TIR
- Special Emphasis Panel for Cancer Immunotherapeutics CII (80)
- Special Emphasis Panel for Immune Oncology R21 CII (81)
- Special Emphasis Panel for Cancer Immunotherapy R21 CII (82)
- Oncological Sciences F07A
- Oncological Sciences F07B
- Training and Career Development: Translational Immunology Oncology and Immunotherapy T07
- Small Business: Cancer Biotherapeutics Development CII (10)
- Small Business: Cancer Immunotherapy Development CII (11)
